Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Digestive & Intestinal Remedies Market

Digestive & Intestinal Remedies Market Size

  • Report ID: GMI11167
  • Published Date: Sep 2024
  • Report Format: PDF

Digestive & Intestinal Remedies Market Size

Digestive And Intestinal Remedies Market size was valued at USD 19.5 billion in 2023 and is projected to grow at a CAGR of 3.5% from 2024 and 2032. The primary driver of this market's growth is the rising incidence of gastrointestinal disorders. Factors such as changing lifestyle habits, decreased physical activity, and shifts in dietary patterns have heightened the prevalence of digestive tract conditions.

 

Notably, the surge in processed food consumption has played a pivotal role in this trend. For example, data from the National Institutes of Health indicates that approximately 20% of the U.S. population is affected by GERD (Gastroesophageal Reflux Disease).
 

Another key driver is the increasing reliance on digital technologies, which, while making tasks less labor-intensive, have inadvertently led to reduced physical activity. This decline in activity is linked to chronic conditions, including obesity and various digestive issues. The World Health Organization reports that over 1 billion individuals worldwide grapple with obesity. Consequently, the rising obesity rates, combined with increasing instances of conditions like constipation, inflammatory bowel disease, gastroesophageal reflux disease, and irritable bowel syndrome, are poised to propel the digestive and intestinal remedies market in the coming years.
 

Digestive and intestinal remedies encompass a wide range of treatments, from medications and supplements to natural solutions, all aimed at addressing issues related to the digestive system and intestines. These remedies, which include laxatives, probiotics, antacids, anti-diarrheal medications, fiber supplements, antispasmodics, and digestive enzymes, are crafted to alleviate symptoms, enhance digestion, bolster gut health, and treat specific gastrointestinal (GI) tract conditions.
 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The digestive & intestinal remedies market was valued at USD 19.5 billion in 2023 and will witness a 3.5% CAGR between 2024 and 2032 driven by the rising incidence of gastrointestinal disorders.

The digestive medicines segment in the digestive & intestinal remedies industry will attain USD 10.3 billion by 2032, due to its specifically formulated to alleviate various digestive issues.

North America digestive & intestinal remedies market was worth USD 8 billion in 2023 and is expected to surpass USD 10.8 billion by 2032, owing to the popularity of over the counter (OTC) digestive solutions.

Abbott Laboratories, Bayer AG, C.H. Boehringer Sohn AG & Co. KG., China Resources Pharmaceutical Group Limited, and Eli Lilly and Company, among others.

Digestive & Intestinal Remedies Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 15
  • Tables & Figures: 219
  • Countries covered: 22
  • Pages: 123
 Download Free Sample